Kim Jeong Moon Aloe Co., Ltd.
⚠️ Moderate Risk
FEI: 3007292644 • Seoul • SOUTH KOREA
FEI Number
3007292644
Location
Seoul
Country
SOUTH KOREAAddress
Baekjae B/D. 1580-10,, , Seoul, , South Korea
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
NO ENGLISH
Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).
LACKS N/C
The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.
LACKS FIRM
The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.
LABELING
The article appears in violation of FPLA because of its placement, form and/or contents statement.
LACKS N/C
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.
CSTIC LBLG
The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.
NO ENGLISH
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
LACKS FIRM
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 7/5/2012 | 53LC06MOISTURIZING (SKIN CARE PREPARATIONS) | San Francisco District Office (SAN-DO) | |
| 6/14/2012 | 65LBU99PROTECTANT N.E.C. | San Francisco District Office (SAN-DO) | |
| 6/14/2012 | 53LC10WRINKLE SMOOTHING (SKIN CARE PREPARATIONS) | San Francisco District Office (SAN-DO) | |
| 1/6/2012 | 66PBL99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C. | 118NOT LISTED | San Francisco District Office (SAN-DO) |
| 4/22/2010 | 31LFT99TEA, DECAFFEINATED, N.E.C. | Baltimore District Office (BLT-DO) | |
| 4/22/2010 | 63RBY06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC) | Baltimore District Office (BLT-DO) | |
| 4/22/2010 | 63XBY99DIAGOSTIC AID (DRUGS) N.E.C. | Baltimore District Office (BLT-DO) | |
| 4/22/2010 | 63XBY99DIAGOSTIC AID (DRUGS) N.E.C. | Baltimore District Office (BLT-DO) | |
| 4/22/2010 | 63XBY99DIAGOSTIC AID (DRUGS) N.E.C. | Baltimore District Office (BLT-DO) | |
| 4/22/2010 | 63XBY99DIAGOSTIC AID (DRUGS) N.E.C. | Baltimore District Office (BLT-DO) | |
| 4/22/2010 | 63XBY99DIAGOSTIC AID (DRUGS) N.E.C. | Baltimore District Office (BLT-DO) | |
| 4/22/2010 | 63XBY99DIAGOSTIC AID (DRUGS) N.E.C. | Baltimore District Office (BLT-DO) |
Frequently Asked Questions
What is Kim Jeong Moon Aloe Co., Ltd.'s FDA import refusal history?
Kim Jeong Moon Aloe Co., Ltd. (FEI: 3007292644) has 12 FDA import refusal record(s) in our database, spanning from 4/22/2010 to 7/5/2012.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Kim Jeong Moon Aloe Co., Ltd.'s FEI number is 3007292644.
What types of violations has Kim Jeong Moon Aloe Co., Ltd. received?
Kim Jeong Moon Aloe Co., Ltd. has been cited for 11 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Kim Jeong Moon Aloe Co., Ltd. come from?
All FDA import refusal data for Kim Jeong Moon Aloe Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.